References
- Burstein A H, Currey J D, Frankel V H, Reilly D T. The ultimate properties of bone tissue: the effects of yielding. J Biomech 1971; 4: 155–8
- Ekeland A, Engesaeter L B, Langeland N. Mechanical properties of fractured and intact rat femora evaluated by bending, torsional and tensile tests. Acta Orthop Scand 1981; 52: 605–13
- Fleisch H. Bisphosphonates in osteoporosis: an introduction. Osteoporosis Int 1993; 3(Suppl 3)3–5
- Flora L, Hassing G S, Cloyd C G, Bevan J A, Parfitt A M, Villa‐nueva A R. The long‐term skeletal effects of EHDP in dogs. Metab Bone Dis Rel Res 1981; 4/5: 289–99
- Frost H M. The biology of fracture healing. An overview for clinicians. I and II. Clin Orthop 1989; 248: 283–309
- Hyvonen P M, Karhi T, Kosma V M, Liimola‐Luoma L, Hanhi‐jarvi H. The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat. Pharmacol Toxicol 1994; 75: 384–90
- Kanis J A, McCloskey E V, Sirtori P, Khan S, Fern D, Eyres K, Aaeon J, Beneton M N. Rationale for the use of clodronate in osteoporosis. Osteoporosis Int 1993; 3(Suppl 2)23–8
- Koranyi E, Bowman E, Knecht C D, Janssen M. Holding power of orthopaedic screws in bone. Clin Orthop 1970; 72: 283–6
- Lenehan T M, Balligand M, Nunamaker D M, Wood F E. Effects of EHDP on fracture healing in dogs. J Orthop Res 1985; 3: 499–507
- Lepola V, Jalovaara P, Vaananen K. The influence of clodronate on the torsional strength of the growing rat tibia in immobilization osteoporosis. Bone 1994; 15: 367–71
- Liberman U A, Weiss S R, Bröil J, Minne H, Quan H, Bell N H, Rodriguez‐Portales J, Downs R W, Dequeker J, Favus M, Seeman E, Recker R R, Capizzi T, Santora A C, Lombardi A, Shah R V, Hirsch L J, Karpf D B. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995; 333: 1437–43
- Madsen J E, Almaas R, Nordsletten L. Strength reduction of the femoral shaft and neck after ipsilateral tibial fracture in the rat. Eur J Exp Musculoskel Res 1995; 4: 65–8
- Mönkkönen J. A one‐year follow‐ up study of the distribution of 14C‐ clodronate in mice and rats. Pharmacol Toxicol 1988; 62: 51–3
- Nordsletten L, Ekeland A. Muscle contraction increases the structural capacity of the lower leg: An in vivo study in the rat. J Orthop Res 1993; 11: 299–304
- Nordsletten L, Kaastad T S, Madsen J E, Reikerås O, Øvstebø R, Strømme J H, Falch J. The development of femoral osteopenia in ovariectomized rats is not reduced by high intensity treadmill training. A mechanical and densitometric study. Calcif Tissue Int 1994a; 55: 436–42
- Nordsletten L, Madsen J E, Almaas R, Rootwelt T, Konttinen Y T, Hukkanen M, Santavirta S. The neuronal regulation of fracture healing. Effects of sciatic nerve resection in rat tibia. Acta Orthop Scand 1994b; 65: 299–304
- Nyman M T, Paavolainen P, Lindholm T S. Clodronate increases the calcium content in fracture callus. An experimental study in rats. Arch Orthop Trauma Surg 1993; 112: 228–31
- Ott S M. Clinical effects of bisphosphonates in involutional osteoporosis. J Bone Miner Res 1993; 8: 597–606, (Suppl)
- Parfitt A M. Use of bisphosphonates in the prevention of bone loss and fractures. Am J Med 1991; 91(5B)42–6
- Rosen H N, Middlebrooks V L, Sullivan E K, Rosenblatt M, Maitland L A, Moses A C, Greenspan S L. Subregion analysis of the rat femur: a sensitive indicator of changes in bone density following treatment with thyroid hormone or bisphosphonates. Calcif Tissue Int 1994; 55: 173–5
- Storm T, Thamsborg G, Steiniche T, Genant H K, Sørensen O H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–71
- Tarvainen R, Olkkonen H, Nevalainen T, Hyvonen P, Arnala I, Alhava E. Effect of clodronate on fracture healing in dener‐vated rats. Bone 1994; 15: 701–5
- Vaes G. Cellular biology and biomechanical mechanism of bone resorption. A review of recent developments on the formation, activation and mode of action of osteoclasts. Clin Orthop 1988; 231: 239–71
- Watts N B, Harris S T, Genant H K, Wasnich R D, Miller P D, Jackson R D, Licata A A, Ross P, Woodson G C, Yanover M J, Mysiw J, Kohse L, Rao M B, Steiger P, Richmond B, Chesnut C H. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 73–9
- Wronski T J, Yen C ‐F, Scott K S. Estrogen and diphosphonate treatment provide long‐term protection against osteopenia in ovariectomized rats. J Bone Miner Res 1991; 6: 387–94